Correlation Between Innate Pharma and Abionyx Pharma

Can any of the company-specific risk be diversified away by investing in both Innate Pharma and Abionyx Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Innate Pharma and Abionyx Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Innate Pharma and Abionyx Pharma SA, you can compare the effects of market volatilities on Innate Pharma and Abionyx Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Innate Pharma with a short position of Abionyx Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Innate Pharma and Abionyx Pharma.

Diversification Opportunities for Innate Pharma and Abionyx Pharma

-0.51

Correlation Coefficient

Innate Pharma  Abionyx Pharma

Excellent diversification

The 3 months correlation between Innate and Abionyx is -0.51. Overlapping area represents the amount of risk that can be diversified away by holding Innate Pharma and Abionyx Pharma SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Abionyx Pharma SA and Innate Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Innate Pharma are associated (or correlated) with Abionyx Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Abionyx Pharma SA has no effect on the direction of Innate Pharma i.e., Innate Pharma and Abionyx Pharma go up and down completely randomly.

Pair Corralation between Innate Pharma and Abionyx Pharma

Assuming the 90 days trading horizon Innate Pharma is expected to generate 8.29 times less return on investment than Abionyx Pharma. In addition to that, Innate Pharma is 1.06 times more volatile than Abionyx Pharma SA. It trades about 0.0 of its total potential returns per unit of risk. Abionyx Pharma SA is currently generating about 0.01 per unit of volatility. If you would invest  125.00  in Abionyx Pharma SA on October 5, 2024 and sell it today you would lose (4.00) from holding Abionyx Pharma SA or give up 3.2% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Innate Pharma  vs.  Abionyx Pharma SA

Innate Pharma

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Innate Pharma are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong technical indicators, Innate Pharma is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Abionyx Pharma SA

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Abionyx Pharma SA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Abionyx Pharma is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Innate Pharma and Abionyx Pharma

The main advantage of trading using opposite Innate Pharma and Abionyx Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Innate Pharma position performs unexpectedly, Abionyx Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abionyx Pharma will offset losses from the drop in Abionyx Pharma's long position.

The idea behind Innate Pharma and Abionyx Pharma SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.